.

A Sound Clinical Investment For Your Patients

The benefits of Robotic Magnetic Navigation (RMN) have been validated by >100 leading hospitals globally treating >100,000 patients. The improvements in outcomes have been demonstrated with scientific rigor in hundreds of scientific publications.

Avoid Complications

Studies have found 72% fewer major complications when using RMN vs manual catheters1

Clinical data suggests a 71% reduction in cardiac perforations during robotic ablation procedures1

Treat Complex Arrhythmias

Robotics enables physicians to treat complex arrhythmias that are difficult or may be impossible to treat otherwise.

.

A Sound Financial Investment For Your Hospital

Calculate Your ROI

Incremental Annual Procedures with Robot*

Average Reimbursement (USD)2

Total Annual Procedures with Robot

X-Ray / Procedure (min)

Average Procedure Time (hr)

* Primary drivers of practice growth include: treating complex arrhythmias that are otherwise not good candidates for catheter ablation, attracting new patients and improved lab efficiency.

Net Present Value

$
0

Payback Period

0
YEARS

Internal Rate of Return

0
%

Other Considerations

The numbers above do not consider the human, organizational, and ultimately financial benefits of improving patient care and staff safety.

Patients

Physicians

0

Avoided Perforations
(10 Years)

0

Hours Standing Wearing Lead Spared (10 Years)

0

Avoided Other Major Complications (10 Years)

0

Minutes of Radiation Exposure Avoided (10 Years)

Patients

0
0

Avoided Perforations
(10 Years)

Avoided Other Major Complications
(10 Years)

Physicians

0
0

Hours Standing Wearing Lead Spared
(10 Years)

Minutes of Radiation Exposure Avoided
(10 Years)

This data is illustrative of potential benefits of a Robotic EP practice but no such benefit is guaranteed and clinical experience may vary widely. Clinical data is available on file at Stereotaxis or at www.RoboticEP.com/Clinical-Data. Cardiac perforation rates reflect data from known published controlled studies of Stereotaxis technology (3,265 patients in total). Other major adverse events reflects average complication rates from all published head-to-head studies (4,675 patients in total) minus perforation rates. Data updated 2020.

By Treating the Untreatable

RMN allows physicians to treat complex arrhythmias and certain patients that would otherwise not be good candidates for a cardiac ablation or cannot be treated with manual catheters.

By Attracting More Patients

Adopting cutting-edge robotic technology allows for competitive differentiation and showcasing of your clinical and technological leadership in the community. Stereotaxis is committed to supporting Robotic EP practices in attracting and educating patients and referral physicians.

For Patients

A single adverse event can cause significant direct and indirect expenses: treatment costs, extended hospital stays, increased insurance and legal expenses, reputational damage, and more. A robust body of evidence demonstrates RMN can reduce adverse events.1

For Physicians and Staff

Operating rooms expose your team to workplace hazards that increase the risk of cancer and orthopedic injury3,4,5. Injuries and missed work days can increase operating costs, lead to missed revenue opportunities, increase insurance and legal expenses, and cause treatment delays for patients. With RMN, physicians perform procedures seated without lead and protected from radiation.

Through Efficient Staffing

RMN procedures are often performed by a single physician with less support required. This differs from manual procedures where the physician is scrubbed in and requires skilled technicians or secondary physicians to manage mapping and ECG systems. Freeing up your staff can increase revenue opportunities and reduce operating costs.

Through Faster Procedures

Studies have shown that complex procedures can be performed faster with RMN. A large 779 patient meta-analysis showed a statistically significant reduction of 26 minutes for VT procedures using RMN6. Some RMN users have performed up to 6 ablations in a day using the system.

Upfront

The cost to establish a Robotic EP program has been significantly reduced with recent innovations. By offering a fully integrated robotic lab including fluoroscopy, a Robotic EP lab can be established at a price similar to a high-end biplane x-ray alone.

Of Each Procedure

The cost of a robotic disposable used in each procedure is often more than counteracted by savings from the reduced use of other disposables such as expensive sheaths, diagnostic catheters or other disposables. While the use of disposable products in ablation procedures varies, we can help you identify ways to reduce disposable costs without compromising patient care.

By Treating the Untreatable

RMN allows physicians to treat complex arrhythmias and certain patients that would otherwise not be good candidates for a cardiac ablation or cannot be treated with manual catheters.

By Attracting More Patients

Adopting cutting-edge robotic technology allows for competitive differentiation and showcasing of your clinical and technological leadership in the community. Stereotaxis is committed to supporting Robotic EP practices in attracting and educating patients and referral physicians.

For Patients

A single adverse event can cause significant direct and indirect expenses: treatment costs, extended hospital stays, increased insurance and legal expenses, reputational damage, and more. A robust body of evidence demonstrates RMN can reduce adverse events.1

For Physicians and Staff

Operating rooms expose your team to workplace hazards that increase the risk of cancer and orthopedic injury2,3,4. Injuries and missed work days can increase operating costs, lead to missed revenue opportunities, increase insurance and legal expenses, and cause treatment delays for patients. With RMN, physicians perform procedures seated without lead and protected from radiation.

Through Efficient Staffing

RMN procedures are often performed by a single physician with less support required. This differs from manual procedures where the physician is scrubbed in and requires skilled technicians or secondary physicians to manage mapping and ECG systems. Freeing up your staff can increase revenue opportunities and reduce operating costs.

Through Faster Procedures

Studies have shown that complex procedures can be performed faster with RMN. A large 779 patient meta-analysis showed a statistically significant reduction of 26 minutes for VT procedures using RMN5. Some RMN users have performed up to 6 ablations in a day using the system.

Upfront

The cost to establish a Robotic EP program has been significantly reduced with recent innovations. By offering a fully integrated robotic lab including fluoroscopy, a Robotic EP lab can be established at a price similar to a high-end biplane x-ray alone.

Of Each Procedure

The cost of a robotic disposable used in each procedure is often more than counteracted by savings from the reduced use of other disposables such as expensive sheaths, diagnostic catheters or other disposables. While the use of disposable products in ablation procedures varies, we can help you identify ways to reduce disposable costs without compromising patient care.

.

A Sound Strategic Investment For Your Institution

You operate in a competitive marketplace and cater to a range of stakeholders. The strategic differentiation offered from establishing a cutting-edge Robotic EP program can be critical to:

  • Attract Patients

  • Recruit Medical Talent

  • Develop Robust Referral Networks

  • Establish Payor Relationships

Showcase your clinical and technological leadership

.

Become a Robotic EP Partner

  1. Data on file as shown on http://www.roboticep.com/clinical-data/
  2. Based on an average reimbursement level of $34,834 determined using 2020 national-average Medicare reimbursement rate of $23,223 (DRG code 273) and assumed national-average private payor rate of $46,446. Patient volume modeled as 50% Medicare and 50% private payor. Assumed premium of 100% for private payors supported by various literature:
    • Lopez E, et al.. How Much More Than Medicare Do Private Insurers Pay? A Review of the Literature. The Henry J. Kaiser Family Foundation. https://www.kff.org/. Published April 15, 2020.
    • Chapin, et al. Private Health Plans Pay Hospitals Much More Than What Medicare Would Pay. RAND Corporation. https://www.rand.org/. Published May 9, 2019.
  3. Roguin A, Goldstein J, Bar O, Goldstein JA. Brain and neck tumors among physicians performing interventional procedures. Am J Cardiol. 2013;111(9):1368-72.
  4. Vano E, Leiman NJ, Duran A, Romano-Miller M, Rehani MM. Radiation-associated lens opacities in catheterization personnel: results of a survey and direct assessments. J Vasc Interv Radiol. 2013;24(2):197-204
  5. Klein LW, Tra Y, Garratt KN, Powell W, Lopez-Cruz G, Chambers C, et al. Occupational health hazards of interventional cardiologists in the current decade: Results of the 2014 SCAI membership survey. Catheter Cardiovasc Interv. 2015;86(5):913-24
  6. Turagam MK, Atkins D, Tung R, Mansour M, Ruskin J, Cheng J, et al. A meta-analysis of manual versus remote magnetic navigation for ventricular tachycardia ablation. J Interv Card Electrophysiology. 2017 Sept;49(3):227-235.

Stereotaxis Intended Use Statements, United States Labeling:

The Genesis RMN® and Niobe® ES Systems are intended to navigate compatible magnetic devices through tissue to designated target sites in the right and left heart, coronary vasculature, neurovasculature, and peripheral vasculature by orienting the device tip in a desired direction. The Cardiodrive® Catheter Advancement System (CAS) is intended to automatically advance and retract  compatible magnetic electrophysiology (EP) mapping and ablation catheters inside a patient’s heart when used in conjunction with a Stereotaxis magnetic navigation system. The Cardiodrive System is not intended to advance the EP mapping and ablation catheters through the coronary vasculature or the coronary sinus.

Consult the associated product labeling for the Indications for Use and instructions of other devices used in conjunction with Stereotaxis products.

Cardiodrive and Niobe are trademarks of Stereotaxis, Inc., registered in the United States, the European Community, and Japan. Genesis RMN is a trademark of Stereotaxis, Inc., registered in the United States.

 

Images: 1, 2, 3, 4